Illinois SR 394: OVARIAN CANCER AWARENESS MO.
Status: Resolution Adopted (as of 2025-10-15)
State: Illinois · Session: 104th · Bill: SR 394
Sponsors: Sara Feigenholtz
Bill Text
• Illinois General Assembly - Full Text of SR0394 • • • • • • • • • • • • Select Language × The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein. Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet. The English language version is always the official and authoritative version of this website. NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window. Choose Language English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Bengali Bosnian Catalan Croatian Czech Danish Dutch Esperanto Estonian Filipino Finnish French Galician Georgian German Greek Gujarati Haitian Creole Hausa Hawaiian Hebrew Hindi Hungarian Icelandic Indonesian Interlingua Interlingue Inuktitut Irish Italian Japanese Javanese Kannada Khmer Korean Latin Latvian Lithuanian Luxembourgish Macedonian Malagasy Malayalam Maltese Maori Marathi Myanmar Nepali Norwegian Odia Pashto Punjabi Romanian Russian Samoan Sango Sanskrit Sardinian Sindhi Sinhala Slovak Slovenian Somali Southern Sotho Spanish Sundanese Swahili Swedish Tamil Telugu Thai Tigrinya Tonga Turkish Ukrainian Urdu Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Powered by Translate Close Illinois General Assembly Top Navigation Bar Translate Learn Select General Assembly Search the 104th General Assembly Enter search terms for legislation, members, committees, or schedules. ILGA.GOV • • LEGISLATION & LAWS • Bills & Resolutions • Public Acts • Illinois Compiled Statutes • Illinois Constitution • Search Legislation • Glossary • Guide • Reports & Inquiry • Legislative Reports • Special Reports • FTP Site • Legislator Lookup • Capitol Complex Phone Numbers • Rules & Regulations • Illinois Register • Administrative Rules • Senate • Members • Schedules • Committees • Request for Remote Testimony • Journals • Transcripts • Rules • Audio/Video • FOIA Information • Senate Employment Opportunities • Media Guidelines • House • Members • Schedules • Committees • Submit testimony for House Committees • Journals • Transcripts • Rules • Audio/Video • FOIA Information • House Employment Opportunities • Log In Mobile Top Bar Search the 104th General Assembly Enter keywords to search the Illinois General Assembly website. Full Text of SR0394 • Home • Legislation • Full Text SR0394 - 104th General Assembly • Bill Status • Full Text • Votes • Witness Slips Select Menu Bill Status Full Text Votes Witness Slips Printer Friendly Version Introduced Printer Friendly Version Introduced Open PDF SR0394LRB104 14115 LAW 27247 r 1SENATE RESOLUTION 2 WHEREAS, Ovarian cancer is the fifth-leading cause of 3cancer deaths of women in the United States and causes more 4deaths than any other gynecologic cancer; and 5 WHEREAS, In the United States, a woman's lifetime risk of 6being diagnosed with ovarian cancer is approximately 1 in 78; 7and 8 WHEREAS, The American Cancer Society estimates 20,890 9cases of ovarian cancer will be newly diagnosed in 2025 and 1012,730 individuals will die from the disease nationwide, 11including 770 new cases and 410 deaths in Illinois; and 12 WHEREAS, The five-year survival rate for ovarian cancer is 1350%, although survival rates vary greatly depending on the 14stage of diagnosis, such as individuals who are diagnosed with 15ovarian cancer in its early stages having a survival rate of 16over 90%; and 17 WHEREAS, While a mammogram can detect breast cancer and a 18Pap smear can detect cervical cancer, there is no reliable 19early detection test for ovarian cancer; and 20 WHEREAS, In June 2007, the first national consensus SR0394- 2 -LRB104 14115 LAW 27247 r 1statement on ovarian cancer symptoms was developed to provide 2consistency in describing symptoms to make it easier for women 3to learn and remember those symptoms; and 4 WHEREAS, Black women with ovarian cancer are more likely 5to have late-stage diagnoses, receive lower quality clinical 6services, and have lower five-year survival rates than 7non-Black women; and 8 WHEREAS, Women of color, low-income women, and women 9living in rural areas have more barriers to accessing standard 10quality of care and are more likely to receive care at a 11facility that has poorer adherence to National Comprehen
View Illinois SR 394 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.